as at 16 October 2023, it has 4,753,717,153 Ordinary Shares of 0.1 pence each in issue and admitted to trading on the London Stock Exchange. Allergy Therapeutics currently does not hold any Ordinary Shares in treasury. Allergy Therapeutics' International Securities Identification Number ("ISIN...
Currently, the Group continues to benefit from the relaxed bank covenants and lower pension contributions that were negotiated in spring 2023, although pension contributions will increase to £50m this year, and capital expenditure will rise back towards normalised levels. In this context, the Board...